EFSA Embraces New Approach Methodologies (NAMs) for Animal-Free Chemical Risk Assessment

August 2, 2026

EFSA (European Food Safety Authority) European Union

Overview

In 2026, the European Food Safety Authority (EFSA) established an advisory group to integrate New Approach Methodologies (NAMs) into its chemical risk assessment, accelerating the EU’s transition to non-animal testing for industrial chemicals, pharmaceuticals, and food additives. This strategic shift leverages NAMs to improve risk assessment for complex substances like nanomaterials, promising a more efficient and ethical future for safety evaluations.

In Depth

Background

Driven by increasing societal awareness of ethical animal treatment and significant advancements in scientific technology, the European Union has actively championed the phasing out of animal testing in the safety assessment of cosmetics and industrial chemicals. This commitment is formalized within the European Commission’s ‘Chemicals Strategy for Sustainability,’ which actively encourages the adoption of New Approach Methodologies (NAMs) in risk assessment. Concurrently, the rapid evolution of nanotechnology has led to a proliferation of innovative products across sectors such as food, medicine, and electronics, creating an urgent demand for robust scientific data and clear regulatory frameworks concerning nanomaterial safety. EFSA’s proactive initiative is directly aligned with these overarching EU strategies, aiming to address both ethical imperatives and the need for scientific rigor in emerging technological domains.

Key Findings

In 2026, the European Food Safety Authority (EFSA) established an internal advisory group specifically tasked with integrating New Approach Methodologies (NAMs) into its chemical risk assessment processes. This strategic development marks a pivotal step in the EU’s broader objective to accelerate the transition towards safety assessments that do not rely on animal testing, encompassing industrial chemicals, pharmaceuticals, and food additives.

NAMs represent a sophisticated suite of advanced assessment tools designed as alternatives to traditional animal testing. These include cutting-edge techniques such as in vitro (test tube) assays, computational toxicology (in silico modeling), high-throughput screening (HTS), and various ‘omics’ technologies (e.g., genomics, proteomics). By synergistically combining these methodologies, scientists can gain a molecular-level understanding of chemical substances’ effects on cells and biological systems, enabling more accurate predictions of potential human health risks.

A key focus for EFSA is the application of NAMs to nanomaterials and nanoparticles. Unlike conventional chemicals, these substances possess unique physicochemical properties—such as size, shape, surface area, and surface charge—that profoundly influence their toxicity mechanisms. EFSA plans to leverage NAMs to meticulously evaluate how nanomaterials are internalized by cells, which intracellular pathways they disrupt, and whether they induce genotoxicity, inflammatory responses, or oxidative stress. This detailed approach is anticipated to facilitate the establishment of more comprehensive and efficient safety profiles for nanomaterials, significantly reducing or eliminating the need for animal testing.

EFSA’s advisory group is mandated to rigorously evaluate the scientific validity of these NAMs and to develop comprehensive guidance for their seamless integration into regulatory decision-making. This effort will be instrumental in achieving the EU’s ambitious goal of phasing out animal testing, while also potentially setting new global standards for chemical and nanomaterial safety assessment. Looking ahead, the scope of NAMs is expected to broaden to cover an even wider array of chemicals and complex materials. However, challenges remain, including the effective integration of data from diverse NAMs, robust extrapolation of findings to human health risks, and achieving harmonization with international regulatory bodies. To address these, EFSA will foster stronger collaborations with research institutions, industry partners, and other regulatory authorities, ensuring the reliability and practical utility of NAMs for a future of sustainable, ethical, and consumer-protective science-based decision-making.

Source: https://www.efsa.europa.eu/en/topics/new-approach-methodologies-nams

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.